دانلود مقاله ISI انگلیسی شماره 129070
ترجمه فارسی عنوان مقاله

نتایج رفتاری و نوروآنتیومیک در یک مدل موشهای مغزی هیپوکسیک-ایسکمیک پیش از قاعدگی: اثرات کافئین و هیپوترمی

عنوان انگلیسی
Behavioral and neuroanatomical outcomes in a rat model of preterm hypoxic-ischemic brain Injury: Effects of caffeine and hypothermia
کد مقاله سال انتشار تعداد صفحات مقاله انگلیسی
129070 2018 36 صفحه PDF
منبع

Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)

Journal : International Journal of Developmental Neuroscience, Available online 21 February 2018

ترجمه کلمات کلیدی
نوزاد نارس، نوزاد مدل حیوانی، رفتار - اخلاق، ناتوانی در رشد، محافظت از عصب
کلمات کلیدی انگلیسی
Premature infant; Neonate; Animal model; Behavior; Developmental disability; Neuroprotection;
پیش نمایش مقاله
پیش نمایش مقاله  نتایج رفتاری و نوروآنتیومیک در یک مدل موشهای مغزی هیپوکسیک-ایسکمیک پیش از قاعدگی: اثرات کافئین و هیپوترمی

چکیده انگلیسی

The current study investigated behavioral and post mortem neuroanatomical outcomes in Wistar rats with a neonatal hypoxic-ischemic (HI) brain injury induced on postnatal day 6 (P6; Rice-Vannucci HI method; Rice et al., 1981). This preparation models brain injury seen in premature infants (gestational age (GA) 32–35 weeks) based on shared neurodevelopmental markers at time of insult, coupled with similar neuropathologic sequelae (Rice et al., 1981; Workman et al., 2013). Clinically, HI insult during this window is associated with poor outcomes that include attention deficit hyperactivity disorder (ADHD), motor coordination deficits, spatial memory deficits, and language/learning disabilities. To assess therapies that might offer translational potential for improved outcomes, we used a P6 HI rat model to measure the behavioral and neuroanatomical effects of two prospective preterm neuroprotective treatments – hypothermia and caffeine. Hypothermia (aka “cooling”) is an approved and moderately efficacious intervention therapy for fullterm infants with perinatal hypoxic-ischemic (HI) injury, but is not currently approved for preterm use. Caffeine is a respiratory stimulant used during removal of infants from ventilation but has shown surprising long-term benefits, leading to consideration as a therapy for HI of prematurity. Current findings support caffeine as a preterm neuroprotectant; treatment significantly improved some behavioral outcomes in a P6 HI rat model and partially rescued neuropathology. Hypothermia treatment (involving core temperature reduction by 4 °C for 5 h), conversely, was found to be largely ineffective and even deleterious for some measures in both HI and sham rats. These results have important implications for therapeutic intervention in at-risk preterm populations, and promote caution in the application of hypothermia protocols to at-risk premature infants without further research.